(19)
(11) EP 4 798 257 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24795190.8

(22) Date of filing: 25.10.2024
(51) International Patent Classification (IPC): 
A61K 51/04(2006.01)
C07B 59/00(2006.01)
A61P 35/00(2006.01)
A61K 103/30(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 51/0497; A61K 51/0402; A61P 35/00; C07B 59/002
(86) International application number:
PCT/EP2024/080276
(87) International publication number:
WO 2025/088147 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 27.10.2023 EP 23206467

(71) Applicant: Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts
69120 Heidelberg (DE)

(72) Inventors:
  • SCHÄFER, Martin
    69239 Neckarsteinach (DE)
  • BAUDER-WUEST, Ulrike
    69198 Schriesheim (DE)
  • ROSCHER, Mareike
    68165 Mannheim (DE)
  • REMDE, Yvonne
    69214 Eppelheim (DE)
  • BENESOVÁ-SCHÄFER, Martina
    69239 Neckarsteinach (DE)
  • BARINKA, Cyril
    19016 Prag (CZ)
  • KUTILOVÁ, Zsófia
    16000 Prag (CZ)
  • MOTLOVÁ, Lucia
    14000 Prag (CZ)

(74) Representative: Altmann Stößel Dick Patentanwälte PartG mbB 
Theodor-Heuss-Anlage 2
68165 Mannheim
68165 Mannheim (DE)

   


(54) THERANOSTIC PSMA-TARGETING LIGANDS FOR THE DIAGNOSIS AND TREATMENT OF PSMA-EXPRESSING CANCERS AND THEIR SOLID PHASE SYNTHESIS